DXR Relative Valuation
DXR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DXR is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for DXR's competitors is 92.16, providing a benchmark for relative valuation. Daxor Corp Corp (DXR) exhibits a P/S ratio of 367.38, which is 298.64% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
META
Meta Platforms Inc
640.430
USD
+0.01%
XOM
Exxon Mobil Corp
106.470
USD
-1.59%
WMT
Walmart Inc
98.120
USD
-0.12%
AMZN
Amazon.com Inc
206.160
USD
+0.28%
AAPL
Apple Inc
208.780
USD
-1.17%
AVGO
Broadcom Inc
230.630
USD
+0.88%
TSLA
Tesla Inc
342.090
USD
-2.25%
NVDA
NVIDIA Corp
135.570
USD
+0.13%
ORCL
Oracle Corp
159.640
USD
-0.53%
MSFT
Microsoft Corp
458.870
USD
+1.01%
FAQ
Is Daxor Corp (DXR) currently overvalued or undervalued?
Daxor Corp (DXR) is now in the Fair zone, suggesting that its current forward PE ratio of 1.53 is considered Fairly compared with the five-year average of 188.59. The fair price of Daxor Corp (DXR) is between 6.71 to 7.78 according to relative valuation methord.
What is Daxor Corp (DXR) fair value?
How does DXR's valuation metrics compare to the industry average?
What is the current P/B ratio for Daxor Corp (DXR) as of May 20 2025?
What is the current FCF Yield for Daxor Corp (DXR) as of May 20 2025?
What is the current Forward P/E ratio for Daxor Corp (DXR) as of May 20 2025?